{
  "id": "NCLEX_NGN_VFIB_SAFETYSTOP_001",
  "type": "selectN",
  "stem": "A 58-year-old male was admitted to the ICU at 0800 following an out-of-hospital cardiac arrest due to ventricular fibrillation (V-Fib). Return of spontaneous circulation (ROSC) was achieved in the field after two defibrillations. The client is intubated, sedated, and receiving targeted temperature management. The nurse is reviewing the client's electronic health record (EHR) before continuing a prescribed infusion. Which actions should the nurse take at this time? Select all that apply.",
  "options": [
    {
      "id": "opt_06",
      "label": "F",
      "content": "Increase the norepinephrine infusion rate to target a higher MAP."
    },
    {
      "id": "opt_05",
      "label": "E",
      "content": "Notify the healthcare provider of the ECG findings."
    },
    {
      "id": "opt_03",
      "label": "C",
      "content": "Place defibrillator/transcutaneous pacer pads on the client."
    },
    {
      "id": "opt_04",
      "label": "D",
      "content": "Request a prescription for an IV beta-blocker."
    },
    {
      "id": "opt_02",
      "label": "B",
      "content": "Administer the scheduled amiodarone infusion."
    },
    {
      "id": "opt_01",
      "label": "A",
      "content": "Withhold the amiodarone infusion."
    }
  ],
  "solution": [
    0,
    2,
    4
  ],
  "exhibits": [
    {
      "id": "exhibit_01",
      "type": "EHR",
      "tabs": [
        {
          "title": "Nurses' Notes",
          "content": "0800: Client admitted to ICU post-ROSC from V-Fib arrest. Intubated, sedated with propofol. Norepinephrine infusion initiated for MAP goal >65 mmHg. Targeted temperature management initiated. Client's partner at bedside, reports client lost their job and health insurance 6 months ago and has not been able to afford cardiology appointments or medications for known heart failure (HFrEF)."
        },
        {
          "title": "Vital Signs",
          "content": "| Time | HR (bpm) | BP (mmHg) | RR (vent) | SpO2 (%) | Temp (Â°C) |\n|---|---|---|---|---|---|\n| 0800 | 72 | 94/58 (MAP 70) | 14 | 96% | 36.1 |\n| 0900 | 60 | 98/62 (MAP 74) | 14 | 95% | 35.5 |\n| 1000 | 48 | 102/64 (MAP 77) | 14 | 95% | 34.8 |"
        },
        {
          "title": "Laboratory Results",
          "content": "| Lab Test | Result | Reference Range |\n|---|---|---|\n| Potassium (K+) | 3.3 mEq/L | 3.5-5.0 mEq/L |\n| Magnesium (Mg++) | 1.5 mg/dL | 1.7-2.2 mg/dL |\n| Troponin I | 24.5 ng/mL | <0.04 ng/mL |\n| Lactate | 4.8 mmol/L | 0.5-2.2 mmol/L |\n| BUN | 28 mg/dL | 7-20 mg/dL |\n| Creatinine | 1.6 mg/dL | 0.6-1.2 mg/dL |"
        },
        {
          "title": "Diagnostic Findings",
          "content": "**12-Lead ECG Interpretation (1000):**\n- Rhythm: Sinus Bradycardia\n- Heart Rate: 48 bpm\n- PR Interval: 180 ms\n- QRS Duration: 90 ms\n- QTc Interval: 550 ms\n- Interpretation: Sinus bradycardia with significant QT prolongation. No evidence of ST-segment elevation myocardial infarction (STEMI)."
        },
        {
          "title": "Medication Administration Record (MAR)",
          "content": "**Continuous Infusions:**\n- Norepinephrine 8 mcg/min IV\n- Propofol 30 mcg/kg/min IV\n\n**Scheduled Medications:**\n- Amiodarone 1 mg/min IV infusion (for arrhythmia suppression post-V-Fib arrest)"
        }
      ]
    }
  ],
  "rationale": {
    "correct": "The synthesis of clinical data reveals a life-threatening situation. The ECG shows a QTc interval of 550 ms, which is severely prolonged (normal <450 ms). Amiodarone, a potassium channel blocker, is known to prolong the QT interval further. Administering it to a client with a baseline prolonged QTc, bradycardia, hypokalemia, and hypomagnesemia creates an imminent risk of Torsades de Pointes (TdP), a lethal polymorphic ventricular tachycardia. The nurse's priority is to recognize this contraindication and take immediate action to prevent a second cardiac arrest. The correct actions are to **withhold the offending agent (amiodarone)**, **notify the provider** of the critical ECG finding, and **proactively prepare for the potential consequences (TdP or worsening bradycardia) by placing pacer pads**. \n\n**Pathophysiology Rationale:** Ventricular fibrillation is a chaotic, disorganized electrical activity in the ventricles, leading to ineffective contraction and cessation of cardiac output. Post-ROSC, maintaining hemodynamic stability and preventing re-fibrillation are crucial. Amiodarone is an antiarrhythmic used to prevent recurrent V-Fib, but it prolongs the QT interval by blocking potassium channels. QT prolongation increases the risk of early afterdepolarizations, which can trigger TdP. Bradycardia, hypokalemia, and hypomagnesemia further exacerbate QT prolongation. Placing defibrillator/pacer pads ensures immediate intervention if TdP or severe bradycardia occurs.",
    "incorrect": "Administering the amiodarone infusion is the most dangerous action and represents a failure to recognize a critical safety stop. This action could directly precipitate a fatal arrhythmia. Requesting a beta-blocker is also unsafe as it would worsen the existing severe bradycardia (HR 48 bpm). Increasing the norepinephrine is not indicated as the MAP is currently stable and above the target of 65 mmHg. While correcting the low potassium is important, stopping the drug that could trigger an immediate fatal arrhythmia is the highest priority.",
    "answerBreakdown": [
      {
        "label": "A",
        "content": "Withhold the amiodarone infusion.",
        "isCorrect": true,
        "justification": "**[+]** This is the most critical and correct action. The client's QTc interval is 550 ms. Amiodarone prolongs the QT interval and administering it would significantly increase the risk of degenerating into Torsades de Pointes. This is a clear 'Don't Proceed' situation based on the ECG data. **Pathophysiology:** Amiodarone blocks potassium channels, prolonging repolarization and the QT interval. A QTc >500ms significantly increases the risk of TdP.",
        "highlight": true
      },
      {
        "label": "B",
        "content": "Administer the scheduled amiodarone infusion.",
        "isCorrect": false,
        "justification": "This is a life-threatening error. Proceeding with the infusion despite the severe QTc prolongation demonstrates a failure to recognize a critical contraindication. This action could directly cause Torsades de Pointes and subsequent cardiac arrest. **Pathophysiology:** Administering amiodarone with a prolonged QTc can lead to early afterdepolarizations, triggering TdP.",
        "highlight": true
      },
      {
        "label": "C",
        "content": "Place defibrillator/transcutaneous pacer pads on the client.",
        "isCorrect": true,
        "justification": "**[+]** This is a crucial proactive safety measure. The combination of severe bradycardia (HR 48 bpm) and a long QT interval puts the client at high risk for both symptomatic bradycardia and Torsades de Pointes. Having pacing and defibrillation capabilities immediately available is essential. **Pathophysiology:** Bradycardia can further prolong the QT interval, increasing the risk of TdP. Pacer pads provide a means to increase the heart rate if bradycardia becomes symptomatic or if TdP occurs. Defibrillation is the treatment for TdP.",
        "highlight": true
      },
      {
        "label": "D",
        "content": "Request a prescription for an IV beta-blocker.",
        "isCorrect": false,
        "justification": "This is contraindicated. The client has sinus bradycardia with a heart rate of 48 bpm. Beta-blockers have negative chronotropic effects and would further decrease the heart rate, potentially leading to hemodynamic instability or asystole. **Pathophysiology:** Beta-blockers decrease heart rate by blocking beta-adrenergic receptors in the heart. This would worsen the existing bradycardia.",
        "highlight": true
      },
      {
        "label": "E",
        "content": "Notify the healthcare provider of the ECG findings.",
        "isCorrect": true,
        "justification": "**[+]** After withholding the medication, immediate communication with the provider is essential. The nurse must report the critical finding of a QTc interval of 550 ms, the bradycardia, and the decision to hold the amiodarone so that the treatment plan can be urgently re-evaluated. **SBAR:**\n*   **Situation:** 58-year-old male, post-ROSC from V-Fib, intubated, sedated, TTM in place.\n*   **Background:** Admitted at 0800. Hx of HFrEF, recently lost job/insurance. Receiving norepinephrine and propofol infusions, scheduled amiodarone.\n*   **Assessment:** 1000 ECG shows sinus bradycardia (HR 48), QTc 550 ms, K+ 3.3, Mg++ 1.5. Amiodarone scheduled.\n*   **Recommendation:** I have withheld the amiodarone due to the prolonged QTc. Recommend re-evaluating the treatment plan given the risk of TdP. I have placed pacer/defibrillator pads.",
        "highlight": true
      },
      {
        "label": "F",
        "content": "Increase the norepinephrine infusion rate to target a higher MAP.",
        "isCorrect": false,
        "justification": "This action is not indicated. The vital signs trend shows the client's MAP is stable and consistently above the goal of 65 mmHg (latest MAP is 77 mmHg). Unnecessarily increasing vasopressors can increase myocardial oxygen demand and is not warranted by the available data. **Pathophysiology:** Norepinephrine is a vasopressor that increases blood pressure by causing vasoconstriction. Increasing it unnecessarily can increase afterload and myocardial oxygen demand.",
        "highlight": true
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Evaluate",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Physiological Adaptation",
    "nclexSubcategory": "Hemodynamics",
    "difficulty": "Hard",
    "topicTags": [
      "Ventricular Fibrillation",
      "Post-Cardiac Arrest Care",
      "Amiodarone",
      "QT Prolongation",
      "Torsades de Pointes",
      "Medication Safety",
      "Critical Care",
      "ECG Interpretation"
    ]
  },
  "clinicalPearls": [
    "A prolonged QTc interval (>500ms) is a critical finding that requires immediate attention, especially in the context of medications known to further prolong the QT interval, such as amiodarone.",
    "Hypokalemia and hypomagnesemia can exacerbate QT prolongation and increase the risk of Torsades de Pointes.",
    "In post-cardiac arrest care, continuous ECG monitoring is crucial for early detection of arrhythmias and QT interval changes.",
    "Always prioritize patient safety by verifying medication orders and assessing for contraindications before administration.",
    "SBAR communication is essential when notifying the healthcare provider of critical findings and changes in patient status.",
    "Proactive placement of defibrillator/pacer pads is a prudent safety measure in patients at high risk for arrhythmias or bradycardia."
  ],
  "sentinelStatus": "healed_v2026_v8"
}